The agency proposed excluding semaglutide, tirzepatide, and liraglutide the active ingredients in popular GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro from the list of drugs that large-scale compounding pharmacies can produce
GLP-1 Receptor : Like semaglutide, retatrutide activates the GLP-1 receptor, leading to increased insulin production, decreased appetite, and slower stomach emptying
The medication creates an environment in your body thats conducive to weight loss, but its up to you to capitalize on these effects through diet and exercise
BMI: No significant difference emerged between the two approaches (SMD 0.02, p = 0.848) meaning fasting reduces overall weight more, but BMI improvements track similarly either way